Overview Financials News + Filings IR Vault Key Docs Charts Ownership Insiders
|
|
MERIDIAN BIOSCIENCE INC (VIVO)
|
Add to portfolio |
|
|
|
| Price: |
$20.69
| | Metrics |
| OS: |
44.0
|
M
| |
-1
|
% ROE
|
| Market cap: |
$911
|
M
| |
|
% ROIC
|
|
Net cash:
|
$49.1
|
M
| |
$1.11
|
per share
|
|
EV:
|
$862
|
M
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
$25.3
|
M
| |
34.1
|
x EV/EBITDA
|
|
EBIT
|
$8.8
|
M
| |
98.0
|
x EV/EBIT
|
| EPS |
($0.07)
| |
|
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Sep-30-22 | Sep-30-21 | Sep-30-20 | Sep-30-19 | Sep-30-18 | Sep-30-17 | Sep-30-16 | Sep-30-15 |
| Revenues | 333.0 | 317.9 | 253.7 | 201.0 | 213.6 | 200.8 | 196.1 | 194.8 |
| Revenue growth | 4.8% | 25.3% | 26.2% | -5.9% | 6.4% | 2.4% | 0.6% | 3.2% |
| Cost of goods sold | 144.7 | 116.7 | 97.4 | 82.3 | 82.5 | 76.5 | 68.9 | 72.9 |
| Gross profit | 188.4 | 201.1 | 156.2 | 118.7 | 131.0 | 124.3 | 127.2 | 121.9 |
| Gross margin | 56.6% | 63.3% | 61.6% | 59.1% | 61.4% | 61.9% | 64.9% | 62.6% |
| Sales and marketing | 31.3 | 26.8 | 26.5 | 28.0 | 34.0 | 32.4 | 30.1 | 25.6 |
| Research and development | 24.3 | 23.9 | 23.7 | 17.8 | 16.6 | 16.0 | 14.2 | 12.6 |
| General and administrative | 57.1 | 49.5 | 44.3 | 34.0 | 35.8 | 31.1 | 29.4 | 27.6 |
| EBITA | 65.4 | 100.9 | 63.5 | 43.5 | 48.1 | 48.5 | 56.2 | 57.8 |
| EBITA margin | 19.6% | 31.7% | 25.0% | 21.6% | 22.5% | 24.2% | 28.7% | 29.7% |
| Amortization of intangibles | 9.9 | 8.8 | 7.7 | 4.5 | 3.4 | 3.8 | 2.7 | 1.7 |
| EBIT | 55.5 | 92.1 | 55.7 | 38.9 | 44.6 | 44.8 | 53.5 | 56.1 |
| EBIT margin | 16.7% | 29.0% | 22.0% | 19.4% | 20.9% | 22.3% | 27.3% | 28.8% |
| Pre-tax income | 54.3 | 90.5 | 59.3 | 31.6 | 30.4 | 36.4 | 50.6 | 55.1 |
| Income taxes | 11.9 | 19.0 | 13.1 | 7.2 | 6.5 | 14.9 | 18.4 | 19.5 |
| Tax rate | 21.8% | 21.1% | 22.1% | 22.7% | 21.5% | 40.8% | 36.4% | 35.5% |
| Net income | 42.5 | 71.4 | 46.2 | 24.4 | 23.8 | 21.6 | 32.2 | 35.5 |
| Net margin | 12.7% | 22.5% | 18.2% | 12.1% | 11.2% | 10.7% | 16.4% | 18.2% |
| |
| Diluted EPS | $0.96 | $1.62 | $1.07 | $0.57 | $0.56 | $0.51 | $0.76 | $0.85 |
| Shares outstanding (diluted) | 44.4 | 44.0 | 43.2 | 42.9 | 42.8 | 42.6 | 42.4 | 42.0 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|